LAUSR

INTRODUCTION We aimed to analyze the influence of cardiovascular risk factors, established cardiovascular diseases and its treatment with cardiovascular drugs on short term and long term survival in patients hospitalized due to COVID-19. PATIENTS AND METHODS We retrospectively analyzed data of patients hospitalized in thirteen COVID - 19 hospitals in Poland (between March 2020 and October 2020). Individual deaths were recorded during follow-up until March 2021. RESULTS Overall 2346 COVID-19 patients were included (mean age 61 years, 50.2% women). 341 patients (14.5%) died during hospitalization and 95 (4.7%) died during follow-up. Independent predictors for in-hospital death were: older age, history of established cardiovascular disease, heart failure (HF), chronic kidney disease (CKD), while treatment with renin-angiotensin-aldosterone system (RAAS) blockers and statins were related with lower risk of death during hospitalization. The independent predictors of death during follow-up were older age, history of established cardiovascular disease, CKD and history of cancer. Presence of cardiovascular risk factors did not increase odds of death either in hospital or during follow-up. Of note, higher systolic blood pressure and oxygen blood saturation on admission were assessed with better short and long term prognosis. CONCLUSION Established cardiovascular disease and chronic kidney disease are the main predictors of mortality during hospitalization and during follow-up in patients hospitalized due to COVID-19, while the use of cardiovascular drugs during hospitalization is associated with better prognosis. The presence of cardiovascular risk factors did not increase odds of in-hospital and follow-up death.